Doctor Care Anywhere Achieves First Profit Amid Strategic Overhaul

A Historic Profit Milestone

Doctor Care Anywhere Group PLC has announced a landmark financial result for the first half of 2025, posting a net profit of £0.5 million; the first in its history. This achievement signals a significant shift for the UK-based telehealth provider, which had previously reported losses, including a £2.7 million loss in the same period last year.

The company attributes this turnaround to a comprehensive transformation of its operating model, which included streamlining operations, reducing fixed overheads, and implementing annual price increases. These measures have collectively enhanced scalability and resilience, positioning the business for sustained profitability.

Revenue Dynamics and Operational Changes

Despite the positive bottom line, revenue for the period declined by 11.8% to £19.2 million, primarily due to the closure of the Secondary Care Pathway in late 2024. However, excluding this closure, the company’s core business revenue actually grew by 1.6%, supported by a 4.75% increase in average price per consultation.

Operationally, Doctor Care Anywhere expanded its clinical workforce by integrating new categories of Advanced Clinical Practitioners, including Mental Health Practitioners and Physiotherapists, alongside existing nurse and pharmacist roles. This diversified clinician mix aims to improve patient outcomes while reducing service delivery costs.

Enhancements to the company’s booking app have also improved the patient experience by significantly reducing appointment scheduling times, contributing to increased engagement and appointment volumes.

Financial Strength and Cash Flow Improvements

EBITDA rose dramatically by 563% to £2.1 million, with an underlying EBITDA of £2.9 million after accounting for £0.8 million in restructuring costs. These restructuring expenses relate to redundancy and consultancy fees as the company continues to optimize productivity.

Importantly, Doctor Care Anywhere generated positive net cash flow of £0.4 million, a stark contrast to the £1.6 million outflow in the prior year. Cash reserves increased to £4.8 million by the period end, bolstered by a £10.6 million convertible loan note issued in January 2024, which replaced a previous loan facility and strengthened the balance sheet.

Joint Venture Exit and Strategic Outlook

The company is in the process of dissolving its joint venture with AXA PPP Healthcare Group Limited, Doctor at Hand Diagnostics Limited, with intellectual property transferred to Doctor Care Anywhere. This move aligns with the company’s focus on consolidating its core telehealth services and streamlining operations.

Looking ahead, management remains cautiously optimistic, emphasizing the importance of managing clinician supply, securing new business, and continuing to drive productivity gains. The directors have affirmed the company’s going concern status, supported by detailed cash flow forecasts and scenario analyses that suggest resilience even under downside conditions.